Tessera Therapeutics names former Merck executive as new CEO
Go back to Tessera Therapeutics names former Merck executive as new CEO| Merck & Co. (NYSE: MRK) | Delayed: 143.79 -0.21 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $144.00 | 52 Week High | $65.46 | |||
| Open | $143.85 | 52 Week Low | $47.97 | |||
| Day High | $144.15 | P/E | 97.82 | |||
| Day Low | $142.32 | EPS | $1.47 | |||
| Volume | 8,296,066 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 774.11 -19.63 (2.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $793.74 | 52 Week High | $592.36 | |||
| Open | $788.53 | 52 Week Low | $325.35 | |||
| Day High | $788.58 | P/E | 203.18 | |||
| Day Low | $769.72 | EPS | $3.81 | |||
| Volume | 540,688 | |||||
